Overall, our research underscores DNAJC1’s pivotal role in glioma pathogenesis and underscores its potential as a significant prognostic biomarker and a candidate for targeted therapy, opening new pathways for advancing glioma diagnostics and treatment. The gene discussed is DNAJC1; the disease is central nervous system cancer.